Literature DB >> 34755253

Treatment of COVID-19 with MSCs: how does it work?

Armand Keating1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34755253      PMCID： PMC8577633          DOI： 10.1007/s11427-021-2022-5

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN： 1674-7305            Impact factor:   10.372


× No keyword cloud information.
  6 in total

Review 1.  Mesenchymal stromal cells: new directions.

Authors:  Armand Keating
Journal:  Cell Stem Cell       Date:  2012-06-14       Impact factor: 24.633

Review 2.  Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines.

Authors:  Guido Moll; James A Ankrum; Julian Kamhieh-Milz; Karen Bieback; Olle Ringdén; Hans-Dieter Volk; Sven Geissler; Petra Reinke
Journal:  Trends Mol Med       Date:  2019-01-30       Impact factor: 11.951

3.  Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia.

Authors:  Zikuan Leng; Rongjia Zhu; Wei Hou; Yingmei Feng; Yanlei Yang; Qin Han; Guangliang Shan; Fanyan Meng; Dongshu Du; Shihua Wang; Junfen Fan; Wenjing Wang; Luchan Deng; Hongbo Shi; Hongjun Li; Zhongjie Hu; Fengchun Zhang; Jinming Gao; Hongjian Liu; Xiaoxia Li; Yangyang Zhao; Kan Yin; Xijing He; Zhengchao Gao; Yibin Wang; Bo Yang; Ronghua Jin; Ilia Stambler; Lee Wei Lim; Huanxing Su; Alexey Moskalev; Antonio Cano; Sasanka Chakrabarti; Kyung-Jin Min; Georgina Ellison-Hughes; Calogero Caruso; Kunlin Jin; Robert Chunhua Zhao
Journal:  Aging Dis       Date:  2020-03-09       Impact factor: 6.745

Review 4.  Mesenchymal stromal cell therapy for coronavirus disease 2019: which? when? and how much?

Authors:  Pradnya Shahani; Indrani Datta
Journal:  Cytotherapy       Date:  2021-04-30       Impact factor: 5.414

5.  Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms.

Authors:  Rongjia Zhu; Tingdong Yan; Yingmei Feng; Yan Liu; Hongcui Cao; Gongxin Peng; Yanlei Yang; Zhen Xu; Jingqi Liu; Wei Hou; Xiaoyue Wang; Zhe Li; Luchan Deng; Shihua Wang; Jing Li; Qin Han; Hongling Li; Guangliang Shan; Yinghao Cao; Xingyan An; Jianshe Yan; Zhonghui Zhang; Huafei Li; Xuebin Qu; Jiaqi Zhu; Shumin Zhou; Jiao Wang; Fengchun Zhang; Jinming Gao; Ronghua Jin; Dayong Xu; Yan-Qing Ma; Tao Huang; Shuang Peng; Zhi Zheng; Ilia Stambler; Eric Gilson; Lee Wei Lim; Alexey Moskalev; Antonio Cano; Sasanka Chakrabarti; Brun Ulfhake; Huanxing Su; Haoying Xu; Sihuan Xu; Feng Wei; Holly M Brown-Borg; Kyung-Jin Min; Georgina Ellison-Hughes; Calogero Caruso; Kunlin Jin; Robert Chunhua Zhao
Journal:  Cell Res       Date:  2021-10-26       Impact factor: 25.617

6.  Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome.

Authors:  Elizabeth A Middleton; Xue-Yan He; Frederik Denorme; Robert A Campbell; David Ng; Steven P Salvatore; Maria Mostyka; Amelia Baxter-Stoltzfus; Alain C Borczuk; Massimo Loda; Mark J Cody; Bhanu Kanth Manne; Irina Portier; Estelle S Harris; Aaron C Petrey; Ellen J Beswick; Aleah F Caulin; Anthony Iovino; Lisa M Abegglen; Andrew S Weyrich; Matthew T Rondina; Mikala Egeblad; Joshua D Schiffman; Christian Con Yost
Journal:  Blood       Date:  2020-09-03       Impact factor: 25.476
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.